Evidence map›Paper›PMID 28827446›Full record

ArticleBioscience reports2017

Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.

Hai-Tao Luo, Cai-Xia Liang, Rong-Cheng Luo, Wei-Guang Gu

Abstract read
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hai-Tao LuoDepartment of Oncology, Affiliated Hospital of South China Sea, Southern Medical University, Foshan 528200, P.R. China.
Cai-Xia LiangDepartment of Respiratory Medicine, Affiliated Hospital of South China Sea, Southern Medical University, Foshan 528200, P.R. China Luohtnanhai624@163.com.
Rong-Cheng LuoDepartment of Oncology, TCM-Integrated Hospital of Southern Medical University, Guangzhou 515000, P.R. China.
Wei-Guang GuDepartment of Oncology, Affiliated Hospital of South China Sea, Southern Medical University, Foshan 528200, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the most common malignant tumors harmful to human health. Cytokeratin (CK) is highly conserved and differentiated related to the proliferation and differentiation of epithelial cells. The aim of the study was to explore expressions of CK20 and CK7 and corresponding prognostic values in patients with lung cancer. Our study included 258 cases of patients confirmed with lung cancer. Expressions of

Indexed as

AdenocarcinomaAdenocarcinoma of LungAdultAgedBiomarkers, TumorFemaleFollow-Up StudiesHumansKeratin-20Keratin-7Lung NeoplasmsLymphatic MetastasisMaleMiddle AgedNeoplasm StagingPrognosisBiomarkers, TumorKeratin-20Keratin-7KRT20 protein, humanCK20CK7lung cancersurvival outcome

Identifiers

PMID28827446
PMCPMC5672087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.